Clinical Trials
2 trialsNCT02718820 2024-01-09
Pembrolizumab Plus Docetaxel for the Treatment of Recurrent or Metastatic Head and Neck Cancer
Medical University of Vienna
Phase 1/2 Completed
NCT03745690 2022-03-17
Near-Infrared Image Guided Surgical Resection With Indocyanine Green in Treating Patients With Head and Neck Cancer
Jonsson Comprehensive Cancer Center
Phase 1/2 Withdrawn